Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
US8399480B2 · kind B2 · utility
23Cited by
0References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 2, 2009 |
| Grant date | Mar 19, 2013 |
| Priority date | — |
| Expiry date | Apr 2, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.